Head and neck cancer during pregnancy
Jennifer Le Guévelou(Centre Eugène Marquis), Juliette Thariat(Centre National de la Recherche Scientifique), Xavier Dufour(Centre Hospitalier Universitaire de Poitiers), B. Baujat(Sorbonne Université), Olivier Mauvais(Centre Hospitalier Universitaire de Besançon), S. Vergèz(Hôpital Rangueil), Sabrina Lebars(Industrial Development Bureau), Audrey Lasne‐Cardon(Centre François Baclesse), F. Jégoux(Centre Hospitalier Universitaire de Rennes), Lise Selleret(Sorbonne Université), Christian Righini(Centre Hospitalier Universitaire de Grenoble), François Janot(Centre Hospitalier Universitaire de Nantes), Emmanuel Kammerer(Centre François Baclesse), Jean‐Claude Merol(Centre Hospitalier Universitaire de Reims), L. de Gabory(Centre Hospitalier Universitaire de Bordeaux)
Cited by 17
Related Papers
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
|International Journal of Radiation Oncology*Biology*Physics|2020|211
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
|Journal of Voice|2020|174
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76